Valuation : Pathkey.AI Ltd

Market Cap 55.37M 39.65M 34.14M 32.06M 29.26M 54.97M 3.77B 380M 148M 1.91B 149M 146M 6.33B P/E 2025
-3.77x
P/E 2026 -8.1x
Enterprise Value 51.96M 37.21M 32.04M 30.08M 27.46M 51.59M 3.54B 356M 139M 1.8B 140M 137M 5.94B EV / Sales 2025
21.1x
EV / Sales 2026 292x
Free-Float
59.45%
Yield 2025 *
-
Yield 2026 -
1 day-4.88%
1 week-9.30%
Current month+34.48%
1 month+34.48%
6 months+56.00%
Current year+143.75%
1 week 0.04
Extreme 0.038
0.05
1 month 0.03
Extreme 0.028
0.05
Current year 0.02
Extreme 0.016
0.08
1 year 0.01
Extreme 0.014
0.08
3 years 0.01
Extreme 0.014
0.08
5 years 0.01
Extreme 0.014
0.2
10 years 0.01
Extreme 0.014
3
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer - 17/01/1994
Chief Executive Officer - 11/05/2026
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman - 21/10/2025
Director/Board Member - 21/10/2025
Chairman - 26/11/2025
Change 5-day change 1-year change 3-year change Capi.($)
-4.88%-9.30%+62.50%-23.53% 39.65M
+3.25%+14.98%+6.13%+36.89% 46.26B
-1.66%-8.79%-40.99%+140.62% 13.42B
+1.19%+8.63%-10.30%+75.20% 5.94B
+5.46%+0.38%+61.71% - 4.38B
-0.39%-13.83% - - 1.96B
+6.29%+1.44%+9.53%-38.16% 1.6B
0.00%-2.04%-35.11% - 1.11B
+0.20%-2.31%+32.98%+150.25% 1.01B
+1.28%-3.10%+49.13%+55.39% 995M
Average +1.07%-1.16%+15.07%+56.67% 7.67B
Weighted average by Cap. +2.21%+7.87%+0.04%+60.41%

Financials

2025 2026
Net sales 322K 231K 199K 186K 170K 320K 21.94M 2.21M 860K 11.13M 866K 847K 36.84M 269K 192K 166K 155K 142K 267K 18.3M 1.84M 717K 9.28M 722K 706K 30.73M
Net income -1.45M -1.04M -893K -838K -765K -1.44M -98.65M -9.93M -3.86M -50.03M -3.89M -3.81M -166M -3.65M -2.62M -2.25M -2.11M -1.93M -3.63M -249M -25.06M -9.75M -126M -9.82M -9.61M -418M
Net Debt -25.17K -18.02K -15.52K -14.57K -13.3K -24.99K -1.71M -173K -67.18K -870K -67.67K -66.2K -2.88M -3.41M -2.44M -2.1M -1.97M -1.8M -3.39M -232M -23.39M -9.1M -118M -9.17M -8.97M -390M
Logo Pathkey.AI Ltd
Opyl Limited is an Australia-based artificial intelligence (AI) company. The Company leverages data and technology to transform the landscape of clinical trials and medical research. It is a digital health company, specialized in leveraging artificial intelligence technologies to elevate clinical trial design and forecast outcomes, empowering clinical researchers, biopharmaceutical corporations, and medical investors to enhance trial design, drug development, and market delivery. Its Social Media Insights solution captures and analyses online public conversations from people living with a medical condition, healthcare professionals, carers, and researchers. Its TrialKey platform provides users access to tailored, actionable steps to address critical trial challenges, improving the likelihood of success. The Company is specialized in applying AI and predictive analytics to social media to accelerate therapy adoption and market development in the healthcare industry.
Employees
-
Date Price Change Volume
01/09/26 A$0.0390 -4.88% 2,397,954
31/08/26 A$0.0410 -8.89% 3,872,218
28/08/26 A$0.0450 +9.76% 12,490,520
27/08/26 A$0.0410 +5.13% 1,035,405
26/08/26 A$0.0390 -4.88% 2,116,294